Drug Database
Back to search

Belgium· BE-AMP-SAM192096-00

Quadramet 1.3 GBq/ml

A samarium (153sm) lexidronam product containing samarium (sm-153) lexidronam pentasodium, registered in Belgium by Cis Bio International. The same ATC class is registered in 8 of our 19 countries.

ATC V10BX02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedQuadramet 1.3 GBq/mlATCV10BX02REGISTER NO.BE-AMP-SAM192096-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about samarium (sm-153) lexidronam pentasodiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Samarium (153sm) lexidronam is registered in 8 of 19 countries.

Countries holding a registration under ATC V10BX02 (samarium (153sm) lexidronam), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 5 of them publish a price we can compare per daily dose
Search samarium (153sm) lexidronam products by name

Samarium (153sm) lexidronam · ATC V10BX02

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Samarium (Sm-153) Lexidronam Pentasodium
Manufacturer
Cis Bio International
Country
Belgium (BE)
ATC code
V10BX02
ATC class
Samarium (153Sm) lexidronam
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    3337870

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Samarium (153sm) lexidronam in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All samarium (153sm) lexidronam products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/203c9a56-4952-4e77-a0a7-7c5ac9be7319
GET /v1/drugs/203c9a56-4952-4e77-a0a7-7c5ac9be7319?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Quadramet 1.3 GBq/ml",
  "name_fr": "Quadramet 1.3 GBq/ml",
  "name_nl": "Quadramet 1.3 GBq/ml",
  "amp_code": "SAM192096-00",
  "strengths": [
    "1.3000",
    "8.1000"
  ],
  "pack_count": 1,
  "substances": [
    "Samarium (Sm-153) Lexidronam Pentasodium",
    "Calcium-EDTMP Sodium",
    "Sodium"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Samarium (153Sm) Lexidronam",
  "authorisation_numbers": [
    "EU/1/97/057/001"
  ]
}
API referenceMCP serverPlans

See everything about samarium (153sm) lexidronam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console